From undruggable to actionable: advances in KRAS targeting in colorectal cancer
KRAS (Kristen rat sarcoma viral oncogene homolog) mutations occur in approximately 40–50% of metastatic colorectal cancer (CRC) cases and have long been associated with resistance to anti-epidermal growth factor receptor (EGFR) therapies and poor clinical outcomes. Historically considered...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Academia.edu Journals
2026-04-01
|
| Цуврал: | Academia Oncology |
| Онлайн хандалт: | https://www.academia.edu/165525801/From_undruggable_to_actionable_advances_in_KRAS_targeting_in_colorectal_cancer |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|